Influenza

 
New Data Highlight Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake
October 17, 2024

IDWeek 2024: Black individuals were less likely to be vaccinated against all 3 respiratory viruses than White individuals, according to new research.

Flu Vaccine Reduced Related Hospitalizations by About One-Third in Southern Hemisphere, but Uptake Still Low
October 07, 2024

Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.

FDA Approves First Self-Administered Flu Vaccine: Daily Dose
September 30, 2024

Your daily dose of the clinical news you may have missed.

First Self-Administered Flu Vaccine Approved by US FDA
September 20, 2024

FluMist is the first influenza vaccine that does not have to be given by a health care professional.

GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3
September 12, 2024

The GSK reformulation induced acceptable immune responses for both influenza A and B strains, overcoming a setback earlier in the ability to successfully neutralize the latter.

Respiratory Virus Vaccines: A Q&A With AAFP President Steven Furr, MD
August 23, 2024

Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.

2024-25 Respiratory Virus Season: AAFP President on How to Get More Shots in Arms
August 14, 2024

Steven Furr, MD, discusses how communication between clinicians and patients is crucial to combatting vaccine hesitancy this upcoming respiratory virus season.

Respiratory Virus Vaccines: AAFP Board Chair on Patient Eligibility, How to Combat Misinformation this Season
July 19, 2024

Encouraging patients to reach out with questions may lead more to roll up their sleeves this season, Tochi Iroku-Malize, MD, told Patient Care.

Intranasal Flu Vaccine Coadministered with High-Dose Shot More Effective in Older Adults than Shot Alone
July 15, 2024

The investigational live intranasal vaccine was safe and well-tolerated when given concomitantly with Fluzone HD and the combination outperformed the latter given by itself.